Heghine Khachatryan: Strengthening Maternal Resilience Against Postpartum Hemorrhage
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared End Postpartum Hemorrhage’s post on LinkedIn, adding:
”Postpartum Hemorrhage (PPH) remains a leading cause of maternal mortality worldwide — and anaemia is a critical, yet often underestimated, contributor.
Strengthening maternal resilience requires a systems-based approach:
- Early identification and treatment of iron deficiency and anaemia during pregnancy
- Structured risk stratification for bleeding
- Access to safe and sufficient blood products
- Integration of haemostasis expertise into obstetric care
- Multidisciplinary emergency preparedness protocols
In many low- and middle-income settings, the intersection of anaemia, limited transfusion capacity, and delayed haemorrhage control creates a preventable cascade of morbidity and mortality.
Addressing PPH is not only about emergency management — it is about prevention, preparedness, and equitable access to diagnostics and treatment.
As hematologists and health policy advocates, we must actively contribute to strengthening national strategies that integrate maternal haemostasis, blood systems, and public health infrastructure.
Maternal survival is a measure of health system equity.”
Quoting End Postpartum Hemorrhage’s post:
”Strengthening Maternal Resilience: Postpartum Haemorrhage (PPH) remains the leading cause of maternal mortality in Kenya.
A critical factor often overlooked is pre-existing anaemia. Addressing this at the antenatal stage is a cost-effective, high-impact strategy for reducing deaths.”
Find more posts featuring Heghine Khachatryan on Hemostasis Today.
-
Mar 31, 2026, 16:05Happy National Doctors’ Day to All Physicians Making a Difference – ASH
-
Mar 31, 2026, 16:03Robert Negrin: Strengthening Collaboration with NCI to Advance Hematology Research
-
Mar 31, 2026, 16:02Jim Hoffman: Does Multiomics Suggest LC PASC Patients Require Multiple Drugs to Correct Biochemical Dysregulation?
-
Mar 31, 2026, 15:59Seema Dawood: Blister Cell in G6PD Deficiency
-
Mar 31, 2026, 15:57Ney Carter Borges: Clopidogrel vs Aspirin in Long-Term Monotherapy
-
Mar 31, 2026, 15:57Join the Webinar on Immunoglobulin Access and Stewardship in the UK and Australia – ISBT
-
Mar 31, 2026, 15:55Hind El Azzazi: Successful Defense of My Medical Doctorate on Antiphospholipid Syndrome in Men
-
Mar 31, 2026, 15:54Rucha Patil: Honored to Speak at AIIMS Nagpur ToT Workshop on Non-Factor Therapy in Hemophilia A
-
Mar 31, 2026, 15:43Deepak Sudheendra: When the Clot Is Gone, but Symptoms Remain